Despite several reports have implicated the aberrant activation and mutation of CTNNB1, to the best of our knowledge, there has been no report to suggest that CTNNB1 to be a direct target of miR-214 in HCC [41], [42]. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.